Posted by Michael Wonder on 30 Nov 2022
How CSL priced the world’s most expensive drug
1 December 2022 - When blood products giant CSL announced last week it had been given US regulatory approval for the world’s first gene therapy for haemophilia B, it did not expect the price of the drug to make global headlines.
But because it has an eye-watering price tag of $US3.5 million ($5 million) a dose, that’s precisely what happened, thanks to the fact its newly named therapy Hemgenix has become the most expensive treatment in the world.
